I-129F Posts a Preliminary 20-Day Drop, but Zero 2026 Cohort Approvals Tell a Different Story

The I-129F final-stage median (the time from a case's last reported status to approval) fell from 197 days the week of July 6 to 177 days the week of July 13, a decline of 20 days. That movement is this week's headline, but it comes with a firm caveat: the sample of 286 approved cases is preliminary, roughly half the prior 12-week median volume, which means the reading can shift as more approvals are recorded. The 12-week trailing average is 175 days, so this week's 177-day figure lands in line with recent experience rather than above or below it in any meaningful way. The 8-week regression slope of -2.2 days per week and an R² of 0.08 confirm there is no clear directional trend; the week-to-week signal is genuinely noisy.

177 days: in line with a noisy range

The clearest summary of I-129F final-stage waits since late April is the 12-week range itself: 146 to 199 days. The most recent three readings alone illustrate the variability: 146 days the week of June 29, then 197 the week of July 6, then 177 this week. There is no steady direction embedded in that sequence. Readers should treat the 177-day figure as one observation within a wide band, not as confirmation that times are improving or worsening.

The stage duration data (from a 30-day raw sample across all active I-129F cases) shows where the caseload is concentrated. Cases at the 'Case Was Received' status account for 40.1% of all active cases, with a median wait of 242 days at that status, a 25th percentile (p25) of 225 days, and a 75th percentile (p75) of 273 days, across 26,668 cases. Another 34.5% of cases have already reached 'Case Was Approved' and are in the post-approval processing window, with a median of 45 days across 22,923 cases. In short, the bulk of the pending caseload sits in the earliest queue, before any adjudication (the USCIS case-decision step) has begun.

Among cases in the approval cohort table (weighted-average percentiles across the last 12 weeks), those at the RFE response stage carry a median of just 11 days, consistent with the rfe_fast anomaly flag that fired this week. The raw stage duration data shows that RFE-response cases cleared at a median of 16 days this week vs. 237 days for the non-RFE path, a ratio of roughly 15 to 1. This counterintuitive pattern may reflect a small batch of RFE responses that happened to resolve quickly in the same week, rather than any structural policy improvement. The data does not tell us why; a single week is not enough to confirm any mechanism.

The filing-month cohort burndown, which tracks cases by the calendar month they were filed and measures what share has been approved as of today, tells the most consequential story in this week's data. Not one case filed in February, March, April, May, June, or July 2026 has been recorded as approved as of the July 27 snapshot. The youngest group, cases filed in July 2026 at age 3 weeks, is naturally expected to be at zero. But the February 2026 group, now at age 25 weeks, also shows 0.0% approved across 3,569 total cases. The active pending backlog across all six cohorts stood at 15,411 cases as of July 27, up 7,619 cases (+97.8%) from roughly 7,792 on May 7, over 81 days.

Approvals are occurring: this preliminary week recorded 286, and the monthly status counts show 761 approvals in October 2025 and 210 in September 2025. Those approvals appear to be legacy cases filed in mid-2025 or earlier, not 2026 cohorts. This is the key distinction the cohort burndown makes plain. The weekly median reflects how long recently approved cases waited; the cohort burndown shows whether recently filed cases have cleared at all. Right now, the answer for every 2026 cohort is the same: none have.

The weekly median tells you how long approved cases waited; the cohort burndown tells you whether recently filed cases have cleared at all.